Literature DB >> 19351643

Recent advances in Clostridium difficile-associated disease.

T Monaghan1, T Boswell, Y R Mahida.   

Abstract

The main purpose of this article is to review recent developments in the management of acute and recurrent Clostridium difficile-associated disease, with consideration of existing and new antibiotic and non-antibiotic agents for treatment. Details of the current developmental stage of new agents are provided and the role of surgery in the management of severe disease is discussed. Infection control measures considered comprise prudent use of antimicrobials, prevention of cross-infection and surveillance. Other topics that are covered include the recent emergence of an epidemic hypervirulent strain, pathogenesis, clinical presentation and approaches to rapid diagnosis and assessment of the colonic disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351643     DOI: 10.1136/gut.2007.128157

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  8 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Enduracidin analogues with altered halogenation patterns produced by genetically engineered strains of Streptomyces fungicidicus.

Authors:  Xihou Yin; Ying Chen; Ling Zhang; Yang Wang; T Mark Zabriskie
Journal:  J Nat Prod       Date:  2010-04-23       Impact factor: 4.050

3.  Sensitive quantification of Clostridium difficile cells by reverse transcription-quantitative PCR targeting rRNA molecules.

Authors:  Kazunori Matsuda; Hirokazu Tsuji; Takashi Asahara; Takuya Takahashi; Hiroyuki Kubota; Satoru Nagata; Yuichiro Yamashiro; Koji Nomoto
Journal:  Appl Environ Microbiol       Date:  2012-05-11       Impact factor: 4.792

4.  Clinical Characteristics of Symptomatic Clostridium difficile Infection in Children: Conditions as Infection Risks and Whether Probiotics Is Effective.

Authors:  Jae Yoon Na; Jong Mo Park; Kyung Suk Lee; Jung Oak Kang; Sung Hee Oh; Yong Joo Kim
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2014-12-31

5.  Biochemical Characterizations of the Putative Endolysin Ecd09610 Catalytic Domain from Clostridioides difficile.

Authors:  Hiroshi Sekiya; Hina Yamaji; Ayumi Yoshida; Risa Matsunami; Shigehiro Kamitori; Eiji Tamai
Journal:  Antibiotics (Basel)       Date:  2022-08-20

6.  Metabolism of bile salts in mice influences spore germination in Clostridium difficile.

Authors:  Jennifer L Giel; Joseph A Sorg; Abraham L Sonenshein; Jun Zhu
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

7.  In Vitro Bactericidal Effects of Photodynamic Therapy Combined with Four Tetracyclines against Clostridioides difficile KCTC5009 in Planktonic Cultures.

Authors:  Sung Sook Choi; Hui Yeong Oh; Eui Jin Kim; Hae Kyung Lee; Hyung Keun Kim; Hyun Ho Choi; Sang Woo Kim; Hiun Suk Chae
Journal:  Pathogens       Date:  2020-04-11

8.  Characterization of an Endolysin Targeting Clostridioides difficile That Affects Spore Outgrowth.

Authors:  Shakhinur Islam Mondal; Arzuba Akter; Lorraine A Draper; R Paul Ross; Colin Hill
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.